Table 1.

Summarized chimerism data of CA mice and control mice in the absence of cytoreductive conditioning and with reduced-intensity myeloablation

GenotypenConditioningFinal RBC chimerismHSPC chimerismGranulocyte chimerism
α2α12α1, γHPFHβ0HPFHβ0 12 anti-CD122, Diprotin A Mean 87.9* 5.2 4.8 
Range 59.3-98.9 0.5-15.7 0.8-10.6 
SEM 3.67 1.28 1.07 
α2α12α1, γHPFHβ0/+ Mean 1.2* ND 1.7 
Range 0.0-4.2 0.0-6.0 
SEM 0.63 0.87 
α2α12α1, +/+ Mean 2.6* ND 1.5 
Range 0.0-6.1 0.0-6.4 
SEM 1.35 1.24 
α2α12α1, γHPFHβ0HPFHβ0 400 rad Mean 99.7 57.7 59.5 
Range 98.8-99.9 15.1-97.1 18.8-83.7 
SEM 0.22 16.84 12.91 
GenotypenConditioningFinal RBC chimerismHSPC chimerismGranulocyte chimerism
α2α12α1, γHPFHβ0HPFHβ0 12 anti-CD122, Diprotin A Mean 87.9* 5.2 4.8 
Range 59.3-98.9 0.5-15.7 0.8-10.6 
SEM 3.67 1.28 1.07 
α2α12α1, γHPFHβ0/+ Mean 1.2* ND 1.7 
Range 0.0-4.2 0.0-6.0 
SEM 0.63 0.87 
α2α12α1, +/+ Mean 2.6* ND 1.5 
Range 0.0-6.1 0.0-6.4 
SEM 1.35 1.24 
α2α12α1, γHPFHβ0HPFHβ0 400 rad Mean 99.7 57.7 59.5 
Range 98.8-99.9 15.1-97.1 18.8-83.7 
SEM 0.22 16.84 12.91 

Chimerism data were collected after 150 d upon euthanasia of recipients. Chimerism values represent percentage of GFP+ donor cells among RBCs, HSPCs (LinSca1+cKit+), and granulocytes (Gr1+). Means, ranges, and SEMs are shown. RBC chimerism was significantly different between CA mice and control mice as determined by 1-way analysis of variance. By the same test, there was no statistically significant difference between granulocyte chimerism levels within the groups undergoing noncytoreductive conditioning.

ND, not determined.

*

P ≤ .00001.

or Create an Account

Close Modal
Close Modal